IKBKG and neoplasm: Previously, NEMO was identified as a tumor suppressor in liver by conditional hepatocyte-specific deletion of NEMO in mice (Luedde et al., 2007; Seki and Brenner, 2007; Kondylis et al., 2015; Mossanen et al., 2019).